miércoles, 30 de octubre de 2024

FDA grants accelerated approval to asciminib for newly diagnosed chronic myeloid leukemia

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-asciminib-newly-diagnosed-chronic-myeloid-leukemia

No hay comentarios:

Publicar un comentario